We found that a small proportion of circulating CD45+CD3-CD14-CD19+CD22+B cells in healthy volunteers (n = 24) and patients with melanoma (n = 49) express the skin-homing Cutaneous Leucocyte-associated Antigen (CLA) (Fig. 1a, Figure S1a). This evidence concerns the gene CD19 and melanoma.